Difficulty: Medium
Average Score: 81%
Practice
Small round blue cell tumors refer to all the following EXCEPT
Correct answer
B
Rationale
In the context of pediatric oncology, small round blue cell tumors represent a diverse group of malignancies that share similar histological features. In this case, the correct answer, option B) osteosarcoma, is not classified as a small round blue cell tumor. Osteosarcoma is a primary bone cancer that typically presents with malignant osteoid formation rather than the characteristic small round blue cell appearance seen in tumors like Ewing sarcoma and rhabdomyosarcoma.
Option A) non-Hodgkin lymphoma is a lymphoid malignancy and is not classified as a small round blue cell tumor. Option C) Ewing sarcoma and option D) rhabdomyosarcoma are both examples of small round blue cell tumors commonly seen in pediatric patients. Ewing sarcoma arises from primitive neuroectodermal cells, while rhabdomyosarcoma originates from skeletal muscle progenitor cells.
Educationally, understanding the histological characteristics and clinical manifestations of different pediatric tumors is crucial for healthcare providers caring for pediatric oncology patients. Recognizing the distinct features of small round blue cell tumors can aid in accurate diagnosis, treatment planning, and prognostication in pediatric oncology practice.
Option A) non-Hodgkin lymphoma is a lymphoid malignancy and is not classified as a small round blue cell tumor. Option C) Ewing sarcoma and option D) rhabdomyosarcoma are both examples of small round blue cell tumors commonly seen in pediatric patients. Ewing sarcoma arises from primitive neuroectodermal cells, while rhabdomyosarcoma originates from skeletal muscle progenitor cells.
Educationally, understanding the histological characteristics and clinical manifestations of different pediatric tumors is crucial for healthcare providers caring for pediatric oncology patients. Recognizing the distinct features of small round blue cell tumors can aid in accurate diagnosis, treatment planning, and prognostication in pediatric oncology practice.